HRP20200408T1 - Mono- ili di-supstituirani derivati indola kao inhibitori replikacije denga virusa - Google Patents
Mono- ili di-supstituirani derivati indola kao inhibitori replikacije denga virusa Download PDFInfo
- Publication number
- HRP20200408T1 HRP20200408T1 HRP20200408TT HRP20200408T HRP20200408T1 HR P20200408 T1 HRP20200408 T1 HR P20200408T1 HR P20200408T T HRP20200408T T HR P20200408TT HR P20200408 T HRP20200408 T HR P20200408T HR P20200408 T1 HRP20200408 T1 HR P20200408T1
- Authority
- HR
- Croatia
- Prior art keywords
- compound
- pharmaceutically acceptable
- solvate
- image
- acceptable salt
- Prior art date
Links
- -1 di-substituted indole Chemical class 0.000 title claims 3
- 208000001490 Dengue Diseases 0.000 title 1
- 206010012310 Dengue fever Diseases 0.000 title 1
- 229940123627 Viral replication inhibitor Drugs 0.000 title 1
- 229940054051 antipsychotic indole derivative Drugs 0.000 title 1
- 208000025729 dengue disease Diseases 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims 11
- 150000003839 salts Chemical class 0.000 claims 6
- 239000012453 solvate Substances 0.000 claims 6
- 239000003814 drug Substances 0.000 claims 3
- 239000000825 pharmaceutical preparation Substances 0.000 claims 3
- 241000725619 Dengue virus Species 0.000 claims 2
- 229940124597 therapeutic agent Drugs 0.000 claims 2
- 239000003443 antiviral agent Substances 0.000 claims 1
- 239000012472 biological sample Substances 0.000 claims 1
- 239000000969 carrier Substances 0.000 claims 1
- 238000011260 co-administration Methods 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 230000010076 replication Effects 0.000 claims 1
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 claims 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/12—Radicals substituted by oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Claims (8)
1. Spoj formule (I)
[image]
njegov stereoizomerni oblik, farmaceutski prihvatljiva sol, solvat ili polimorf koji sadrži mono- ili di-supstituiranu indolnu skupinu; navedeni spoj je odabran iz skupine pri čemu:
R1 je H, R2 je F ili Cl i R3 je H ili CH3;
R1 je F, R2 je F i R3 je H;
R1 je CH3, R2 je OCH3 i R3 je H;
R1 je CH3, R2 je F i R3 je H;
R1 je CH3, R2 je H i R3 je F;
R1 je Cl, R2 je H i R3 je CH3;
R1 je OCF3, R2 je H ili OCH3 i R3 je H i
R1 je OCF3R, R2 je H i R3 je CH3.
2. Spoj ili njegov stereoizomerni oblik, njegova farmaceutski prihvatljiva sol, solvat ili polimorf prema zahtjevu 1 naznačen time što je navedeni spoj odabran iz skupine koju čine:
[image]
[image]
[image]
[image]
3. Farmaceutski pripravak, naznačen time što sadrži spoj formule (I) ili njegov stereoizomerni oblik, njegovu farmaceutski prihvatljivu sol, solvat ili polimorf prema zahtjevu 1 ili 2 zajedno s jednom ili više farmaceutski prihvatljivih pomoćnih tvari, razrjeđivača ili nosača.
4. Spoj formule (I) ili njegov stereoizomerni oblik, farmaceutski prihvatljiva sol, solvat ili polimorf prema zahtjevu 1 ili farmaceutski pripravak prema zahtjevu 3 naznačen time što se koristi kao lijek.
5. Spoj formule (I) ili njegov stereoizomerni oblik, farmaceutski prihvatljiva sol, solvat ili polimorf prema zahtjevu 1 ili farmaceutski pripravak prema zahtjevu 3 naznačen time što je namijenjen upotrebi u liječenju denga virusa.
6. Spoj koji je predstavljen slijedećom strukturnom formulom (I)
[image]
njegov stereoizomerni oblik, farmaceutski prihvatljiva sol, solvat ili polimorf koji sadrže mono- ili di-supstituiranu indolnu skupinu; te je navedeni spoj je odabran iz skupine u kojoj:
R1 je H, R2 je F ili Cl i R3 je H ili CH3;
R1 je F, R2 je F i R3 je H;
R1 je CH3, R2 je OCH3 i R3 je H;
R1 je CH3, R2 je F i R3 je H;
R1 je CH3, R2 je H i R3 je F;
R1 je Cl, R2 je H i R3 je CH3;
R1 je OCF3, R2 je H ili OCH3 i R3 je H i
R1 je OCF3, R2 je H i R3 je CH3
naznačen time što je namijenjen upotrebi za inhibiranje replikacije denga virusa u biološkom uzorku ili pacijentu.
7. Spoj za uporabu prema zahtjevu 6 naznačen time što nadalje obuhvaća zajedničko davanje dodatnog terapijskog sredstva.
8. Spoj za uporabu prema zahtjevu 7 naznačen time što je navedeno dodatno terapeutsko sredstvo drugo antivirusno sredstvo.
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP15185522 | 2015-09-16 | ||
| EP16163465 | 2016-04-01 | ||
| EP16767235.1A EP3350163B1 (en) | 2015-09-16 | 2016-09-15 | Mono- or di-substituted indole derivatives as dengue viral replication inhibitors |
| PCT/EP2016/071852 WO2017046258A1 (en) | 2015-09-16 | 2016-09-15 | Mono- or di-substituted indole derivatives as dengue viral replication inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20200408T1 true HRP20200408T1 (hr) | 2020-06-12 |
Family
ID=56958913
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HRP20200408TT HRP20200408T1 (hr) | 2015-09-16 | 2020-03-12 | Mono- ili di-supstituirani derivati indola kao inhibitori replikacije denga virusa |
Country Status (37)
| Country | Link |
|---|---|
| US (1) | US10786484B2 (hr) |
| EP (1) | EP3350163B1 (hr) |
| JP (2) | JP7045984B2 (hr) |
| KR (1) | KR102676442B1 (hr) |
| CN (1) | CN108368044B (hr) |
| AU (1) | AU2016323535B2 (hr) |
| CA (1) | CA2996856C (hr) |
| CL (1) | CL2018000697A1 (hr) |
| CO (1) | CO2018003369A2 (hr) |
| CR (1) | CR20180214A (hr) |
| CY (1) | CY1122792T1 (hr) |
| DK (1) | DK3350163T3 (hr) |
| EA (1) | EA035679B1 (hr) |
| EC (1) | ECSP18020039A (hr) |
| ES (1) | ES2778431T3 (hr) |
| HK (1) | HK1258320A1 (hr) |
| HR (1) | HRP20200408T1 (hr) |
| IL (1) | IL258031B (hr) |
| JO (1) | JO3633B1 (hr) |
| LT (1) | LT3350163T (hr) |
| MA (1) | MA42811B1 (hr) |
| MD (1) | MD3350163T2 (hr) |
| ME (1) | ME03674B (hr) |
| MX (1) | MX2018003256A (hr) |
| MY (1) | MY188347A (hr) |
| NI (1) | NI201800040A (hr) |
| PE (1) | PE20181007A1 (hr) |
| PH (1) | PH12018500569A1 (hr) |
| PL (1) | PL3350163T3 (hr) |
| PT (1) | PT3350163T (hr) |
| RS (1) | RS60039B1 (hr) |
| SI (1) | SI3350163T1 (hr) |
| TW (1) | TWI758256B (hr) |
| UA (1) | UA123672C2 (hr) |
| UY (1) | UY36904A (hr) |
| WO (1) | WO2017046258A1 (hr) |
| ZA (1) | ZA201801764B (hr) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201116559D0 (en) | 2011-09-26 | 2011-11-09 | Univ Leuven Kath | Novel viral replication inhibitors |
| KR101818521B1 (ko) * | 2011-11-16 | 2018-01-16 | 대우조선해양 주식회사 | 마이크로채널 열교환기용 2상 유체 공급장치 및 그 방법 |
| GB201305376D0 (en) | 2013-03-25 | 2013-05-08 | Univ Leuven Kath | Novel viral replication inhibitors |
| JOP20160086B1 (ar) | 2015-05-08 | 2021-08-17 | 2 Katholieke Univ Leuven Ku Leuven Research And Development | مشتقات اندول مستبدلة احاديا او ثنائيا بصفتها مانعات للتكاثر الفيروسي لحمى الفنك |
| JOP20160198B1 (ar) | 2015-09-16 | 2022-03-14 | Janssen Pharmaceuticals Inc | مشتقات اندول مستبدلة احاديا او ثنائيا بصفتها مانعات للتكاثر الفيروسي لحمى الفنك |
| US10695323B2 (en) | 2015-12-16 | 2020-06-30 | Loxo Oncology, Inc. | Compounds useful as kinase inhibitors |
| WO2017167953A1 (en) | 2016-03-31 | 2017-10-05 | Janssen Pharmaceuticals, Inc. | Substituted indoline derivatives as dengue viral replication inhibitors |
| CN108884033B (zh) | 2016-03-31 | 2021-03-09 | 杨森制药公司 | 作为登革病毒复制抑制剂的经取代的吲哚衍生物 |
| MA44502A (fr) | 2016-04-01 | 2019-02-06 | Janssen Pharmaceuticals Inc | Dérivés d'indole substitués utilisés en tant qu'inhibiteurs de réplication du virus de la dengue |
| JOP20170069B1 (ar) | 2016-04-01 | 2021-08-17 | 1 Janssen Pharmaceuticals Inc | مشتقات اندولين مستبدلة بصفتها مانعات للتكاثر الفيروسي لحمى الفنك |
| JOP20180025B1 (ar) * | 2017-03-31 | 2021-08-17 | Janssen Pharmaceuticals Inc | مشتقات اندولين مستبدلة بصفتها مانعات للتكاثر الفيروسي لحمى الفنك |
| JOP20180026A1 (ar) * | 2017-03-31 | 2019-01-30 | Univ Leuven Kath | مشتقات اندولين مستبدلة بصفتها مانعات للتكاثر الفيروسي لحمى الفنك |
| US11053196B2 (en) | 2017-05-22 | 2021-07-06 | Janssen Pharmaceuticals, Inc. | Substituted indoline derivatives as dengue viral replication inhibitors |
| AU2018274100B2 (en) | 2017-05-22 | 2022-06-23 | Janssen Pharmaceuticals, Inc. | Substituted indoline derivatives as dengue viral replication inhibitors |
| WO2024178504A1 (en) * | 2023-02-27 | 2024-09-06 | Enveric Biosciences Canada Inc. | Tri-halo-alkoxy-substituted tryptamine derivatives and methods of using |
Family Cites Families (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0110832D0 (en) | 2001-05-03 | 2001-06-27 | Virogen Ltd | Antiviral compounds |
| JP2005520795A (ja) | 2001-12-12 | 2005-07-14 | コンフォーマ・セラピューティクス・コーポレイション | Ｈｓｐ９０阻害活性を有するプリン類似体 |
| GB0215293D0 (en) | 2002-07-03 | 2002-08-14 | Rega Foundation | Viral inhibitors |
| KR20070098914A (ko) | 2005-01-14 | 2007-10-05 | 제네랩스 테크놀로지스, 인코포레이티드 | 바이러스 감염을 치료하기 위한 인돌 유도체 |
| JP2008530124A (ja) | 2005-02-09 | 2008-08-07 | ミジェニックス インコーポレイテッド | フラビウイルス感染症を処置または予防するための組成物および方法 |
| FR2928645A1 (fr) * | 2008-03-14 | 2009-09-18 | Sanofi Aventis Sa | Nouveaux derives de carbazole inhibiteurs d'hsp90, compositions les contenant et utilisation |
| BRPI0909985A2 (pt) | 2008-06-03 | 2015-08-25 | Siga Technologies Inc | Composição farmacêutica e método para o tratamento ou profilaxia de uma infecção viral ou doença associada à mesma |
| EP2326631A4 (en) * | 2008-08-18 | 2012-03-21 | Univ Yale | MODULATORS OF MIF |
| US8143259B2 (en) | 2008-08-19 | 2012-03-27 | Janssen Pharmaceutica, Nv | Cold menthol receptor antagonists |
| TWI453207B (zh) | 2008-09-08 | 2014-09-21 | Signal Pharm Llc | 胺基三唑并吡啶，其組合物及使用其之治療方法 |
| GB0910003D0 (en) * | 2009-06-11 | 2009-07-22 | Univ Leuven Kath | Novel compounds for the treatment of neurodegenerative diseases |
| US8993604B2 (en) | 2009-06-30 | 2015-03-31 | Siga Technologies, Inc. | Treatment and prevention of dengue virus infections |
| EA201290575A1 (ru) | 2010-01-15 | 2013-01-30 | Джилид Сайэнс, Инк. | Ингибиторы вирусов flaviviridae |
| JP5716205B2 (ja) | 2011-03-29 | 2015-05-13 | 学校法人日本大学 | グルコシダーゼ活性阻害用組成物及びそのスクリーニング方法 |
| GB201116559D0 (en) * | 2011-09-26 | 2011-11-09 | Univ Leuven Kath | Novel viral replication inhibitors |
| GB201305376D0 (en) | 2013-03-25 | 2013-05-08 | Univ Leuven Kath | Novel viral replication inhibitors |
| JP6030035B2 (ja) | 2013-09-27 | 2016-11-24 | 富士フイルム株式会社 | 蛍光観察装置、内視鏡システム及びプロセッサ装置並びに作動方法 |
| US9567299B2 (en) * | 2013-10-23 | 2017-02-14 | Janssen Sciences Ireland Uc | Carboxamide derivatives and the use thereof as medicaments for the treatment of hepatitis B |
| US20170002006A1 (en) | 2014-01-31 | 2017-01-05 | Bristol-Myers Squibb Company | Macrocycles with hetrocyclic p2' groups as factor xia inhibitors |
| NO2721243T3 (hr) | 2014-10-01 | 2018-10-20 | ||
| KR102478309B1 (ko) | 2014-10-01 | 2022-12-15 | 얀센 파마슈티칼즈, 인코포레이티드 | 뎅기 바이러스 복제 억제제로서의 １치환 또는 ２치환 인돌 |
| PL3201176T3 (pl) | 2014-10-01 | 2019-06-28 | Janssen Pharmaceuticals, Inc. | Mono- lub di-podstawione pochodne indolowe jako inhibitory replikacji wirusa dengi |
| JOP20150335B1 (ar) * | 2015-01-16 | 2022-03-14 | Janssen Pharmaceuticals Inc | مشتقات اندول بصفتها مانعات للتكاثر الفيروسي لحمى الفنك |
| AR103680A1 (es) | 2015-02-23 | 2017-05-24 | Lilly Co Eli | Inhibidores selectivos de bace1 |
| JOP20160086B1 (ar) | 2015-05-08 | 2021-08-17 | 2 Katholieke Univ Leuven Ku Leuven Research And Development | مشتقات اندول مستبدلة احاديا او ثنائيا بصفتها مانعات للتكاثر الفيروسي لحمى الفنك |
| JOP20160198B1 (ar) | 2015-09-16 | 2022-03-14 | Janssen Pharmaceuticals Inc | مشتقات اندول مستبدلة احاديا او ثنائيا بصفتها مانعات للتكاثر الفيروسي لحمى الفنك |
| AU2016350868B2 (en) | 2015-11-03 | 2022-03-31 | Zoetis Services Llc | Sol-gel polymer composites and uses thereof |
| WO2017167953A1 (en) | 2016-03-31 | 2017-10-05 | Janssen Pharmaceuticals, Inc. | Substituted indoline derivatives as dengue viral replication inhibitors |
| US10323026B2 (en) | 2016-03-31 | 2019-06-18 | Takeda Pharmaceutical Company Limited | Heterocyclic compound |
| CN108884033B (zh) | 2016-03-31 | 2021-03-09 | 杨森制药公司 | 作为登革病毒复制抑制剂的经取代的吲哚衍生物 |
| MA44502A (fr) | 2016-04-01 | 2019-02-06 | Janssen Pharmaceuticals Inc | Dérivés d'indole substitués utilisés en tant qu'inhibiteurs de réplication du virus de la dengue |
| SG11201808388QA (en) | 2016-04-01 | 2018-10-30 | Signal Pharm Llc | Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith |
| EP3436079B1 (en) | 2016-04-01 | 2021-08-25 | Kite Pharma, Inc. | Chimeric antigen and t cell receptors and methods of use |
| JOP20170069B1 (ar) | 2016-04-01 | 2021-08-17 | 1 Janssen Pharmaceuticals Inc | مشتقات اندولين مستبدلة بصفتها مانعات للتكاثر الفيروسي لحمى الفنك |
| TN2018000337A1 (en) | 2016-04-01 | 2020-01-16 | Amgen Inc | Chimeric receptors to flt3 and methods of use thereof |
| SI3436030T1 (sl) | 2016-04-01 | 2023-01-31 | Kite Pharma, Inc. | Himerni receptorji in načini njihove uporabe |
| CA3015934A1 (en) | 2016-04-01 | 2017-10-05 | Basf Se | Bicyclic compounds |
| JOP20180025B1 (ar) | 2017-03-31 | 2021-08-17 | Janssen Pharmaceuticals Inc | مشتقات اندولين مستبدلة بصفتها مانعات للتكاثر الفيروسي لحمى الفنك |
| JOP20180026A1 (ar) | 2017-03-31 | 2019-01-30 | Univ Leuven Kath | مشتقات اندولين مستبدلة بصفتها مانعات للتكاثر الفيروسي لحمى الفنك |
| AU2018274100B2 (en) | 2017-05-22 | 2022-06-23 | Janssen Pharmaceuticals, Inc. | Substituted indoline derivatives as dengue viral replication inhibitors |
| US11053196B2 (en) | 2017-05-22 | 2021-07-06 | Janssen Pharmaceuticals, Inc. | Substituted indoline derivatives as dengue viral replication inhibitors |
-
2016
- 2016-09-06 JO JOP/2016/0197A patent/JO3633B1/ar active
- 2016-09-13 TW TW105129691A patent/TWI758256B/zh active
- 2016-09-15 SI SI201630686T patent/SI3350163T1/sl unknown
- 2016-09-15 EP EP16767235.1A patent/EP3350163B1/en active Active
- 2016-09-15 JP JP2018513845A patent/JP7045984B2/ja active Active
- 2016-09-15 MD MDE20180704T patent/MD3350163T2/ro unknown
- 2016-09-15 UA UAA201804016A patent/UA123672C2/uk unknown
- 2016-09-15 AU AU2016323535A patent/AU2016323535B2/en active Active
- 2016-09-15 CA CA2996856A patent/CA2996856C/en active Active
- 2016-09-15 MX MX2018003256A patent/MX2018003256A/es unknown
- 2016-09-15 PE PE2018000391A patent/PE20181007A1/es unknown
- 2016-09-15 CR CR20180214A patent/CR20180214A/es unknown
- 2016-09-15 PT PT167672351T patent/PT3350163T/pt unknown
- 2016-09-15 WO PCT/EP2016/071852 patent/WO2017046258A1/en active Application Filing
- 2016-09-15 LT LTEP16767235.1T patent/LT3350163T/lt unknown
- 2016-09-15 CN CN201680053589.9A patent/CN108368044B/zh active Active
- 2016-09-15 ES ES16767235T patent/ES2778431T3/es active Active
- 2016-09-15 PL PL16767235T patent/PL3350163T3/pl unknown
- 2016-09-15 US US15/759,844 patent/US10786484B2/en active Active
- 2016-09-15 DK DK16767235.1T patent/DK3350163T3/da active
- 2016-09-15 ME MEP-2020-53A patent/ME03674B/me unknown
- 2016-09-15 MY MYPI2018000378A patent/MY188347A/en unknown
- 2016-09-15 EA EA201890723A patent/EA035679B1/ru not_active IP Right Cessation
- 2016-09-15 RS RS20200272A patent/RS60039B1/sr unknown
- 2016-09-15 KR KR1020187009485A patent/KR102676442B1/ko active IP Right Grant
- 2016-09-15 MA MA42811A patent/MA42811B1/fr unknown
- 2016-09-16 UY UY0001036904A patent/UY36904A/es not_active Application Discontinuation
-
2018
- 2018-03-12 IL IL258031A patent/IL258031B/en active IP Right Grant
- 2018-03-14 EC ECIEPI201820039A patent/ECSP18020039A/es unknown
- 2018-03-15 NI NI201800040A patent/NI201800040A/es unknown
- 2018-03-15 ZA ZA2018/01764A patent/ZA201801764B/en unknown
- 2018-03-15 CL CL2018000697A patent/CL2018000697A1/es unknown
- 2018-03-15 PH PH12018500569A patent/PH12018500569A1/en unknown
- 2018-03-26 CO CONC2018/0003369A patent/CO2018003369A2/es unknown
-
2019
- 2019-01-16 HK HK19100688.6A patent/HK1258320A1/zh not_active IP Right Cessation
-
2020
- 2020-03-12 CY CY20201100216T patent/CY1122792T1/el unknown
- 2020-03-12 HR HRP20200408TT patent/HRP20200408T1/hr unknown
-
2021
- 2021-08-20 JP JP2021135171A patent/JP2021193092A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20200408T1 (hr) | Mono- ili di-supstituirani derivati indola kao inhibitori replikacije denga virusa | |
| HRP20210847T1 (hr) | Supstituirani derivati indola kao inhibitori replikacije denga virusa | |
| HRP20211278T1 (hr) | Supstituirani derivati indolina kao inhibitori replikacije denga virusa | |
| HRP20210942T1 (hr) | Supstituirani derivati indolina kao inhibitori replikacije denga virusa | |
| HRP20211223T1 (hr) | Heterociklički indoli za upotrebu kod infekcije virusom influence | |
| HRP20211224T1 (hr) | Derivati pirimidina za liječenje virusnih infekcija | |
| HRP20210038T1 (hr) | Pirolopirimidini za uporabu u infekciji virusom gripe | |
| HRP20202051T1 (hr) | Aril supstituirani pirimidini za uporabu kod infekcije virusom influence | |
| HRP20211102T1 (hr) | Supstituirani derivati indolina kao inhibitori replikacije denga virusa | |
| HRP20170654T1 (hr) | Makrociklički deaza-purinoni za liječenje virusnih infekcija | |
| JP2019509276A5 (hr) | ||
| EA201891876A1 (ru) | Тетрациклические пиридоновые соединения в качестве противовирусных средств | |
| JP2017531619A5 (hr) | ||
| JP2019510034A5 (hr) | ||
| HRP20211782T1 (hr) | Derivati indola kao inhibitori replikacije denga virusa | |
| EA201650029A1 (ru) | Пиразолопиридины и пиразолопиримидины | |
| AR111820A1 (es) | Derivados de indolina sustituidos como inhibidores de la replicación de virus del dengue | |
| AR111878A1 (es) | Derivados de indolina sustituidos como inhibidores de la replicación vírica de dengue | |
| HRP20161379T1 (hr) | Inhibitori hepatitis c virusa | |
| HRP20161125T1 (hr) | Makrociklički purini za liječenje virusnih infekcija | |
| JP2019510027A5 (hr) | ||
| EA202090486A3 (ru) | Соединения для лечения спинальной мышечной атрофии | |
| EA201791019A1 (ru) | Полициклические карбамоилпиридоновые соединения и их фармацевтическое применение | |
| BR112014001798A2 (pt) | compostos de tetraciclina 9-aminometila substituídos | |
| BR112012000287B8 (pt) | composição farmacêutica para um inibidor de protease viral de hepatite c |